8-24466980-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000175238.10(ADAM7):āc.571A>Gā(p.Lys191Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000117 in 1,612,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000175238.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM7 | NM_003817.4 | c.571A>G | p.Lys191Glu | missense_variant | 6/22 | ENST00000175238.10 | NP_003808.2 | |
ADAM7-AS1 | NR_125808.1 | n.80-78989T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM7 | ENST00000175238.10 | c.571A>G | p.Lys191Glu | missense_variant | 6/22 | 1 | NM_003817.4 | ENSP00000175238.5 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000208 AC: 52AN: 250506Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135562
GnomAD4 exome AF: 0.000111 AC: 162AN: 1460692Hom.: 0 Cov.: 30 AF XY: 0.0000991 AC XY: 72AN XY: 726710
GnomAD4 genome AF: 0.000177 AC: 27AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2024 | The c.571A>G (p.K191E) alteration is located in exon 6 (coding exon 6) of the ADAM7 gene. This alteration results from a A to G substitution at nucleotide position 571, causing the lysine (K) at amino acid position 191 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at